Drugs for Malaria Market - Global Outlook and Forecast 2021-2027

March 2021 | 90 pages | ID: DAB8DD145804EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Drugs for Malaria in global, including the following market information:

Global Drugs for Malaria Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Drugs for Malaria Market Sales, 2016-2021, 2022-2027, (K Units)

Global top five Drugs for Malaria companies in 2020 (%)

The global Drugs for Malaria market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs for Malaria manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Drugs for Malaria Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Drugs for Malaria Market Segment Percentages, By Type, 2020 (%)

• Aryl Aminoalcohol Compounds
• Antifolate Compounds
• Artemisinin Compounds

Global Drugs for Malaria Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Drugs for Malaria Market Segment Percentages, By Application, 2020 (%)

• Prevention
• Treatment
• Others

Global Drugs for Malaria Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Drugs for Malaria Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Drugs for Malaria revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Drugs for Malaria revenues share in global market, 2020 (%)

Key companies Drugs for Malaria sales in global market, 2016-2021 (Estimated), (K Units)

Key companies Drugs for Malaria sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Cipla
• Guilin Pharmaceutical
• IPCA Laboratories
• GlaxoSmithKline
• Mylan Labs
• Roche
• Novartis
• Sanofi Aventis
• Ajanta Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Drugs for Malaria Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Drugs for Malaria Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DRUGS FOR MALARIA OVERALL MARKET SIZE

2.1 Global Drugs for Malaria Market Size: 2021 VS 2027
2.2 Global Drugs for Malaria Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Drugs for Malaria Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Drugs for Malaria Players in Global Market
3.2 Top Global Drugs for Malaria Companies Ranked by Revenue
3.3 Global Drugs for Malaria Revenue by Companies
3.4 Global Drugs for Malaria Sales by Companies
3.5 Global Drugs for Malaria Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Drugs for Malaria Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Drugs for Malaria Product Type
3.8 Tier 1, Tier 2 and Tier 3 Drugs for Malaria Players in Global Market
  3.8.1 List of Global Tier 1 Drugs for Malaria Companies
  3.8.2 List of Global Tier 2 and Tier 3 Drugs for Malaria Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Drugs for Malaria Market Size Markets, 2021 & 2027
  4.1.2 Aryl Aminoalcohol Compounds
  4.1.3 Antifolate Compounds
  4.1.4 Artemisinin Compounds
4.2 By Type - Global Drugs for Malaria Revenue & Forecasts
  4.2.1 By Type - Global Drugs for Malaria Revenue, 2016-2021
  4.2.2 By Type - Global Drugs for Malaria Revenue, 2022-2027
  4.2.3 By Type - Global Drugs for Malaria Revenue Market Share, 2016-2027
4.3 By Type - Global Drugs for Malaria Sales & Forecasts
  4.3.1 By Type - Global Drugs for Malaria Sales, 2016-2021
  4.3.2 By Type - Global Drugs for Malaria Sales, 2022-2027
  4.3.3 By Type - Global Drugs for Malaria Sales Market Share, 2016-2027
4.4 By Type - Global Drugs for Malaria Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Drugs for Malaria Market Size, 2021 & 2027
  5.1.2 Prevention
  5.1.3 Treatment
  5.1.4 Others
5.2 By Application - Global Drugs for Malaria Revenue & Forecasts
  5.2.1 By Application - Global Drugs for Malaria Revenue, 2016-2021
  5.2.2 By Application - Global Drugs for Malaria Revenue, 2022-2027
  5.2.3 By Application - Global Drugs for Malaria Revenue Market Share, 2016-2027
5.3 By Application - Global Drugs for Malaria Sales & Forecasts
  5.3.1 By Application - Global Drugs for Malaria Sales, 2016-2021
  5.3.2 By Application - Global Drugs for Malaria Sales, 2022-2027
  5.3.3 By Application - Global Drugs for Malaria Sales Market Share, 2016-2027
5.4 By Application - Global Drugs for Malaria Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Drugs for Malaria Market Size, 2021 & 2027
6.2 By Region - Global Drugs for Malaria Revenue & Forecasts
  6.2.1 By Region - Global Drugs for Malaria Revenue, 2016-2021
  6.2.2 By Region - Global Drugs for Malaria Revenue, 2022-2027
  6.2.3 By Region - Global Drugs for Malaria Revenue Market Share, 2016-2027
6.3 By Region - Global Drugs for Malaria Sales & Forecasts
  6.3.1 By Region - Global Drugs for Malaria Sales, 2016-2021
  6.3.2 By Region - Global Drugs for Malaria Sales, 2022-2027
  6.3.3 By Region - Global Drugs for Malaria Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Drugs for Malaria Revenue, 2016-2027
  6.4.2 By Country - North America Drugs for Malaria Sales, 2016-2027
  6.4.3 US Drugs for Malaria Market Size, 2016-2027
  6.4.4 Canada Drugs for Malaria Market Size, 2016-2027
  6.4.5 Mexico Drugs for Malaria Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Drugs for Malaria Revenue, 2016-2027
  6.5.2 By Country - Europe Drugs for Malaria Sales, 2016-2027
  6.5.3 Germany Drugs for Malaria Market Size, 2016-2027
  6.5.4 France Drugs for Malaria Market Size, 2016-2027
  6.5.5 U.K. Drugs for Malaria Market Size, 2016-2027
  6.5.6 Italy Drugs for Malaria Market Size, 2016-2027
  6.5.7 Russia Drugs for Malaria Market Size, 2016-2027
  6.5.8 Nordic Countries Drugs for Malaria Market Size, 2016-2027
  6.5.9 Benelux Drugs for Malaria Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Drugs for Malaria Revenue, 2016-2027
  6.6.2 By Region - Asia Drugs for Malaria Sales, 2016-2027
  6.6.3 China Drugs for Malaria Market Size, 2016-2027
  6.6.4 Japan Drugs for Malaria Market Size, 2016-2027
  6.6.5 South Korea Drugs for Malaria Market Size, 2016-2027
  6.6.6 Southeast Asia Drugs for Malaria Market Size, 2016-2027
  6.6.7 India Drugs for Malaria Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Drugs for Malaria Revenue, 2016-2027
  6.7.2 By Country - South America Drugs for Malaria Sales, 2016-2027
  6.7.3 Brazil Drugs for Malaria Market Size, 2016-2027
  6.7.4 Argentina Drugs for Malaria Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Drugs for Malaria Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Drugs for Malaria Sales, 2016-2027
  6.8.3 Turkey Drugs for Malaria Market Size, 2016-2027
  6.8.4 Israel Drugs for Malaria Market Size, 2016-2027
  6.8.5 Saudi Arabia Drugs for Malaria Market Size, 2016-2027
  6.8.6 UAE Drugs for Malaria Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 Cipla
  7.1.1 Cipla Corporate Summary
  7.1.2 Cipla Business Overview
  7.1.3 Cipla Drugs for Malaria Major Product Offerings
  7.1.4 Cipla Drugs for Malaria Sales and Revenue in Global (2016-2021)
  7.1.5 Cipla Key News
7.2 Guilin Pharmaceutical
  7.2.1 Guilin Pharmaceutical Corporate Summary
  7.2.2 Guilin Pharmaceutical Business Overview
  7.2.3 Guilin Pharmaceutical Drugs for Malaria Major Product Offerings
  7.2.4 Guilin Pharmaceutical Drugs for Malaria Sales and Revenue in Global (2016-2021)
  7.2.5 Guilin Pharmaceutical Key News
7.3 IPCA Laboratories
  7.3.1 IPCA Laboratories Corporate Summary
  7.3.2 IPCA Laboratories Business Overview
  7.3.3 IPCA Laboratories Drugs for Malaria Major Product Offerings
  7.3.4 IPCA Laboratories Drugs for Malaria Sales and Revenue in Global (2016-2021)
  7.3.5 IPCA Laboratories Key News
7.4 GlaxoSmithKline
  7.4.1 GlaxoSmithKline Corporate Summary
  7.4.2 GlaxoSmithKline Business Overview
  7.4.3 GlaxoSmithKline Drugs for Malaria Major Product Offerings
  7.4.4 GlaxoSmithKline Drugs for Malaria Sales and Revenue in Global (2016-2021)
  7.4.5 GlaxoSmithKline Key News
7.5 Mylan Labs
  7.5.1 Mylan Labs Corporate Summary
  7.5.2 Mylan Labs Business Overview
  7.5.3 Mylan Labs Drugs for Malaria Major Product Offerings
  7.5.4 Mylan Labs Drugs for Malaria Sales and Revenue in Global (2016-2021)
  7.5.5 Mylan Labs Key News
7.6 Roche
  7.6.1 Roche Corporate Summary
  7.6.2 Roche Business Overview
  7.6.3 Roche Drugs for Malaria Major Product Offerings
  7.6.4 Roche Drugs for Malaria Sales and Revenue in Global (2016-2021)
  7.6.5 Roche Key News
7.7 Novartis
  7.7.1 Novartis Corporate Summary
  7.7.2 Novartis Business Overview
  7.7.3 Novartis Drugs for Malaria Major Product Offerings
  7.4.4 Novartis Drugs for Malaria Sales and Revenue in Global (2016-2021)
  7.7.5 Novartis Key News
7.8 Sanofi Aventis
  7.8.1 Sanofi Aventis Corporate Summary
  7.8.2 Sanofi Aventis Business Overview
  7.8.3 Sanofi Aventis Drugs for Malaria Major Product Offerings
  7.8.4 Sanofi Aventis Drugs for Malaria Sales and Revenue in Global (2016-2021)
  7.8.5 Sanofi Aventis Key News
7.9 Ajanta Pharma
  7.9.1 Ajanta Pharma Corporate Summary
  7.9.2 Ajanta Pharma Business Overview
  7.9.3 Ajanta Pharma Drugs for Malaria Major Product Offerings
  7.9.4 Ajanta Pharma Drugs for Malaria Sales and Revenue in Global (2016-2021)
  7.9.5 Ajanta Pharma Key News

8 GLOBAL DRUGS FOR MALARIA PRODUCTION CAPACITY, ANALYSIS

8.1 Global Drugs for Malaria Production Capacity, 2016-2027
8.2 Drugs for Malaria Production Capacity of Key Manufacturers in Global Market
8.3 Global Drugs for Malaria Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 DRUGS FOR MALARIA SUPPLY CHAIN ANALYSIS

10.1 Drugs for Malaria Industry Value Chain
10.2 Drugs for Malaria Upstream Market
10.3 Drugs for Malaria Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Drugs for Malaria Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Drugs for Malaria in Global Market
Table 2. Top Drugs for Malaria Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Drugs for Malaria Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Drugs for Malaria Revenue Share by Companies, 2016-2021
Table 5. Global Drugs for Malaria Sales by Companies, (K Units), 2016-2021
Table 6. Global Drugs for Malaria Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Drugs for Malaria Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Drugs for Malaria Product Type
Table 9. List of Global Tier 1 Drugs for Malaria Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Malaria Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Drugs for Malaria Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Drugs for Malaria Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Drugs for Malaria Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Drugs for Malaria Sales (K Units), 2016-2021
Table 15. By Type - Global Drugs for Malaria Sales (K Units), 2022-2027
Table 16. By Application – Global Drugs for Malaria Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Drugs for Malaria Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Drugs for Malaria Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Drugs for Malaria Sales (K Units), 2016-2021
Table 20. By Application - Global Drugs for Malaria Sales (K Units), 2022-2027
Table 21. By Region – Global Drugs for Malaria Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Drugs for Malaria Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Drugs for Malaria Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Drugs for Malaria Sales (K Units), 2016-2021
Table 25. By Region - Global Drugs for Malaria Sales (K Units), 2022-2027
Table 26. By Country - North America Drugs for Malaria Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Drugs for Malaria Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Drugs for Malaria Sales, (K Units), 2016-2021
Table 29. By Country - North America Drugs for Malaria Sales, (K Units), 2022-2027
Table 30. By Country - Europe Drugs for Malaria Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Drugs for Malaria Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Drugs for Malaria Sales, (K Units), 2016-2021
Table 33. By Country - Europe Drugs for Malaria Sales, (K Units), 2022-2027
Table 34. By Region - Asia Drugs for Malaria Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Drugs for Malaria Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Drugs for Malaria Sales, (K Units), 2016-2021
Table 37. By Region - Asia Drugs for Malaria Sales, (K Units), 2022-2027
Table 38. By Country - South America Drugs for Malaria Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Drugs for Malaria Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Drugs for Malaria Sales, (K Units), 2016-2021
Table 41. By Country - South America Drugs for Malaria Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Drugs for Malaria Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Drugs for Malaria Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Drugs for Malaria Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Drugs for Malaria Sales, (K Units), 2022-2027
Table 46. Cipla Corporate Summary
Table 47. Cipla Drugs for Malaria Product Offerings
Table 48. Cipla Drugs for Malaria Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Guilin Pharmaceutical Corporate Summary
Table 50. Guilin Pharmaceutical Drugs for Malaria Product Offerings
Table 51. Guilin Pharmaceutical Drugs for Malaria Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. IPCA Laboratories Corporate Summary
Table 53. IPCA Laboratories Drugs for Malaria Product Offerings
Table 54. IPCA Laboratories Drugs for Malaria Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. GlaxoSmithKline Corporate Summary
Table 56. GlaxoSmithKline Drugs for Malaria Product Offerings
Table 57. GlaxoSmithKline Drugs for Malaria Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Mylan Labs Corporate Summary
Table 59. Mylan Labs Drugs for Malaria Product Offerings
Table 60. Mylan Labs Drugs for Malaria Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Roche Corporate Summary
Table 62. Roche Drugs for Malaria Product Offerings
Table 63. Roche Drugs for Malaria Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Novartis Corporate Summary
Table 65. Novartis Drugs for Malaria Product Offerings
Table 66. Novartis Drugs for Malaria Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. Sanofi Aventis Corporate Summary
Table 68. Sanofi Aventis Drugs for Malaria Product Offerings
Table 69. Sanofi Aventis Drugs for Malaria Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 70. Ajanta Pharma Corporate Summary
Table 71. Ajanta Pharma Drugs for Malaria Product Offerings
Table 72. Ajanta Pharma Drugs for Malaria Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 73. Drugs for Malaria Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 74. Global Drugs for Malaria Capacity Market Share of Key Manufacturers, 2019-2021
Table 75. Global Drugs for Malaria Production by Region, 2016-2021 (K Units)
Table 76. Global Drugs for Malaria Production by Region, 2022-2027 (K Units)
Table 77. Drugs for Malaria Market Opportunities & Trends in Global Market
Table 78. Drugs for Malaria Market Drivers in Global Market
Table 79. Drugs for Malaria Market Restraints in Global Market
Table 80. Drugs for Malaria Raw Materials
Table 81. Drugs for Malaria Raw Materials Suppliers in Global Market
Table 82. Typical Drugs for Malaria Downstream
Table 83. Drugs for Malaria Downstream Clients in Global Market
Table 84. Drugs for Malaria Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Drugs for Malaria Segment by Type
Figure 2. Drugs for Malaria Segment by Application
Figure 3. Global Drugs for Malaria Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Drugs for Malaria Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Drugs for Malaria Revenue, 2016-2027 (US$, Mn)
Figure 7. Drugs for Malaria Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Drugs for Malaria Revenue in 2020
Figure 9. By Type - Global Drugs for Malaria Sales Market Share, 2016-2027
Figure 10. By Type - Global Drugs for Malaria Revenue Market Share, 2016-2027
Figure 11. By Type - Global Drugs for Malaria Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Drugs for Malaria Sales Market Share, 2016-2027
Figure 13. By Application - Global Drugs for Malaria Revenue Market Share, 2016-2027
Figure 14. By Application - Global Drugs for Malaria Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Drugs for Malaria Sales Market Share, 2016-2027
Figure 16. By Region - Global Drugs for Malaria Revenue Market Share, 2016-2027
Figure 17. By Country - North America Drugs for Malaria Revenue Market Share, 2016-2027
Figure 18. By Country - North America Drugs for Malaria Sales Market Share, 2016-2027
Figure 19. US Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Drugs for Malaria Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Drugs for Malaria Sales Market Share, 2016-2027
Figure 24. Germany Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 25. France Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Drugs for Malaria Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Drugs for Malaria Sales Market Share, 2016-2027
Figure 33. China Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 37. India Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Drugs for Malaria Revenue Market Share, 2016-2027
Figure 39. By Country - South America Drugs for Malaria Sales Market Share, 2016-2027
Figure 40. Brazil Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Drugs for Malaria Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Drugs for Malaria Sales Market Share, 2016-2027
Figure 44. Turkey Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Drugs for Malaria Revenue, (US$, Mn), 2016-2027
Figure 48. Global Drugs for Malaria Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Drugs for Malaria by Region, 2020 VS 2027
Figure 50. Drugs for Malaria Industry Value Chain
Figure 51. Marketing Channels